Statistics for ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma
Total visits
| views | |
|---|---|
| ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma | 116 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| nihms-1618693.pdf | 224 |
| java.util.UUID:8283a926-aaf3-4e91-90f1-0d7e3da16970 | 68 |
| java.util.UUID:b471b8fc-844e-43fd-b90a-8e474a6dd662 | 15 |
| java.util.UUID:519b47bf-6a6c-4339-a82f-3dc23ff9d9cb | 9 |
Top country views
| views | |
|---|---|
| United States | 93 |
| Canada | 2 |
| Russia | 2 |
| China | 1 |
| Czechia | 1 |
| South Korea | 1 |
| Malaysia | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 42 |
| White Plains | 13 |
| Fairfield | 9 |
| Houston | 9 |
| San Francisco | 5 |
| Ann Arbor | 2 |
| Toronto | 2 |
| Baltimore | 1 |
| Beijing | 1 |
| Kansas City | 1 |
| Kemerovo | 1 |
| Monmouth Junction | 1 |
| Moscow | 1 |
| Sacramento | 1 |
| Seremban | 1 |
| Slapanice | 1 |
| Stockholm | 1 |